Allylic polyenyl diphosphates such as geranyl and (E,E,E)-geranylgeranyl diphosphates are ubiquitous substrates for monoterpene and diterpene synthases and transferases in isoprenoid biosynthesis. These enzyme substrates were prepared in asymmetrically labeled form by reduction of 1-deuterio aldehyde precursors with (R)- and (S)-Alpine boranes®, conversion into diethyl phosphates, and SN2 displacements with tris(tetrabutylammonium) pyrophosphate which occurred slowly with essentially complete inversion of configuration over 2-5 days. The 8α- and 8β-hydroxy-17-nor analogs (13 and 14) of copalyl diphosphate as well as the (15R)-deuterium-labeled form of 13 were similarly prepared from nor-diols 11, (15S)-[15-2H1]-11, and 12 by means of regioselective phosphorylation of the allylic hydroxy groups and displacements with pyrophosphate anion. The configurations and enantiopurities of the deuterium-labeled geraniols, before and after the SN2 displacements, and the diastereopurity of the bicyclic keto alcohol intermediate (15S)-[15-2H1]-15 were determined by conversion into (1S)-camphanate esters and 1H-NMR analysis. Amino alcohol 18 was similarly converted into amino diphosphate 19, 15-aza-14,15-dihydro GGPP, a potential aza analog inhibitor for diterpene synthases which generate stereoisomeric forms of copalyl diphosphate.
No takes yet. Share an insight, caveat, or question.
Ravn et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: